The FMS‐like tyrosine kinase 3 (FLT3) domain is the most mutated gene in acute myeloid leukemia (AML), with FLT3 internal tandem duplication (ITD) mutations conferring adverse outcomes [1, 2]. This evidence concerns the gene CSF1R and acute myeloid leukemia.